Supplement Claims for Anxiety: What the Evidence Supports

Walk into any health food shop and you’ll find shelves of supplements marketed for anxiety: magnesium, ashwagandha, L-theanine, CBD, passionflower, lavender, valerian, and more. Some have research behind them. Most of that research is much weaker than the marketing suggests.

For how mechanism claims relate to proof of benefit, see mechanism vs proven benefit.

The evidence landscape

The general pattern across anxiety supplements is consistent: a plausible biological mechanism, some positive results in small trials, and then a market that treats preliminary findings as established fact. Here’s what exists for the most popular options.

Magnesium

Magnesium is involved in hundreds of enzymatic processes, including neurotransmitter function. A systematic review of magnesium supplementation for anxiety found suggestive but low-quality evidence [1]. Most studies were small, used different forms and doses of magnesium, and had methodological limitations. The most reasonable interpretation is that supplementation may help people who are magnesium-deficient (which is not uncommon), but evidence for benefit beyond correcting deficiency is weak.

Ashwagandha

Ashwagandha (Withania somnifera) has the most structured trial data among herbal anxiolytics. A systematic review found five RCTs, all showing anxiety reduction [2]. A more recent meta-analysis confirmed a significant effect. But the typical trial has 30–60 participants per group, runs for 6–8 weeks, and several are funded by supplement manufacturers. The evidence is promising but nowhere near the level required for a confident clinical recommendation.

Lavender (Silexan)

Silexan, a proprietary lavender oil preparation, has the unusual distinction of being tested in a large, well-designed trial against both placebo and an active comparator (paroxetine, an SSRI). In 539 participants with GAD, Silexan performed comparably to paroxetine and significantly better than placebo [3]. This is one of the strongest pieces of evidence for any anxiety supplement. But it’s a single large trial, for one specific proprietary preparation, and it needs independent replication.

CBD

CBD (cannabidiol) has generated enormous consumer interest. Laboratory studies show that a single high dose (300–600 mg) can reduce anxiety in experimental settings like simulated public speaking [4]. But clinical trials in people with anxiety disorders are very few and small. The doses used in research are typically 10–20 times higher than what most consumer products contain. Long-term safety data is limited, and product quality varies enormously in an unregulated market.

L-theanine

L-theanine, an amino acid from tea, has a small number of trials. One RCT in 30 healthy adults found some reduction in stress-related symptoms [5]. But 30 participants is too few to draw reliable conclusions, and the trial measured multiple outcomes, increasing the risk of chance findings. The evidence is very preliminary.

Other herbals

A comprehensive review of plant-based medicines for anxiety covered passionflower, valerian, kava and others [6]. Kava had the strongest evidence but was withdrawn from several markets due to rare liver toxicity concerns. Passionflower had very limited evidence. Valerian showed little consistent benefit for anxiety specifically.

Why the evidence stays weak

Funding. Pharmaceutical companies fund large trials because they can recoup costs through patents. Supplement manufacturers have less incentive and less capital for large trials, because supplements are generally not patentable. This means even promising substances rarely get the large, rigorous trials they need.

Regulatory standards. Supplements are regulated as foods, not drugs, in most jurisdictions. They don’t need to demonstrate efficacy before being sold. This removes the economic pressure to conduct proper trials.

Product variability. Unlike standardized medications, supplement preparations vary in active ingredient content, bioavailability and purity. A trial of one ashwagandha extract may not apply to a different brand’s product.

Publication bias. The same publication bias that affects drug trials applies here, probably more so, since supplement trials are often smaller and less likely to be pre-registered.

Questions to ask about supplement claims

1. Is there at least one randomized, placebo-controlled trial in humans with anxiety?
2. How large was the trial, and who funded it?
3. Is the specific preparation tested the same as what’s being sold?
4. Was the trial in people with diagnosed anxiety disorders or healthy volunteers?
5. How does the effect size compare with established treatments?

What remains uncertain

Whether any supplement can meaningfully add to standard anxiety treatment as an adjunct is poorly studied. Whether combinations of supplements work differently from single agents is essentially unknown. Whether individual variation in response (genetic, dietary, microbiome-related) explains why some people report benefit and others don’t is speculative. The field needs larger, independent trials with standardized preparations and adequate follow-up. Until then, the evidence supports cautious interest, not confident recommendations.

Considering supplements. If you’re thinking about supplements for anxiety, discuss it with your doctor or pharmacist, especially if you take other medications. Supplements should not replace evidence-based treatment. If anxiety is affecting your daily life, talk to a GP or mental health professional. If you are in crisis or thinking about harming yourself, contact emergency services or a crisis line now: in the US, call or text 988; in the UK and Ireland, Samaritans on 116 123.